Amarin Receives Approval for VAZKEPA to Reduce Cardiovascular Risk
A round of applause for our research site physicians Dr Sam Henein and Dr Michael O’Mahony for their participation in the Amarin REDUCE-IT hypertriglyceridemia study!
We have written a number of articles that we hope will be of interest to you. This includes health guides for various medical conditions; news about drug development and regulatory issues related to Health Canada and the FDA; and other health-related topics. Clicking on the title of a Health Guide will take you to information on that medical condition. Or click on one of the listed topics, such as Industry News or Diabetes. You can also access recent articles by scrolling down the page or clicking an article under ‘Recent Articles’.
A round of applause for our research site physicians Dr Sam Henein and Dr Michael O’Mahony for their participation in the Amarin REDUCE-IT hypertriglyceridemia study!
The US Food and Drug Administration (FDA) has granted approval to GlaxoSmithKline (GSK) for Arexvy, the world’s first vaccine designed to protect older adults against respiratory syncytial virus (RSV). RSV is a common respiratory virus that can cause serious illness, particularly in adults over 65 years of age, and in infants and young children. It
The Food and Drug Administration (FDA) of the United States of America has recently issued a statement, updating Research Sites, Investigators, and IRBs on how best to deal with the ongoing challenges posed by COVID-19. These guidelines will help ensure the safety of trial participants, compliance with good clinical practice (GCP), and minimizing risks to
New research conducted by the University of Oxford in partnership with several American institutions has revealed a potential cause of endometriosis and a nonhormonal drug target that may lead to improved therapy for this condition. Endometriosis is when the kind of tissue that normally lines the uterus grows somewhere else. It can grow on the ovaries,
JoinAStudy.ca Investigators Dr. Peter Dzongowski, Dr. Michael Jones and Dr. Sean Peterson were all recently involved in GSK trial AReSVi 006, evaluating a vaccine candidate for Respiratory Syncytial Virus (RSV). Recruitment was highly successful for all three investigators, whose work has helped lead to the first RSV vaccine candidate to show statistically significant and clinically
Earlier this year, we reported on the positive findings of a Covid-19 treatment study, conducted by lead study author and JoinAStudy Investigator Dr. Anil Gupta. We are now proud to highlight that as of November 18, 2021 this research has been published in the prestigious New England Journal of Medicine. It is among the most reputable peer-reviewed medical
Swiss and Italian scientists have been able to prove a correlation between gut microbiota and the appearance of amyloid plaques in the brain, buildups typically associated with Alzheimer’s disease. Alzheimer’s disease is the most common cause of dementia and is an incurable condition that directly affects millions of people, and indirectly affects many more family
Analysis of data from 6.2 million people has found no significant associations between mRNA COVID-19 vaccines and serious side effects. The study authors, based in cities across the United States, undertook this study to compare mRNA vaccines’ negative effects in the first 21 days post-vaccination to negative effects occurring 22 days + after vaccination. Safe and